Search research articles
Contact Us
Filters
Showing results (921-930 of 935) with videos related to
Page
of 94
Sort By:
Lancet (London, England)
|
June 6, 2024
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Hans Gelderblom, Vivek Bhadri, Silvia Stacchiotti, et al.
Scientific Reports
|
October 23, 2020
Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome
Cristina E Trevino, Aaron M Holleman, Holly Corbitt, et al.
Blood
|
March 31, 2023
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia
Zhenhua Li, Ti-Cheng Chang, Jacob J Junco, et al.
American Journal of Human Genetics
|
June 17, 2026
Complete chromosome 21 centromere sequencing of families with Down syndrome
F Kumara Mastrorosa, Alessia Daponte, Luciana de Gennaro, et al.
The Journal of Molecular Diagnostics : JMD
|
January 1, 2008
Consensus characterization of 16 FMR1 reference materials: a consortium study
Jean Amos Wilson, Victoria M Pratt, Amit Phansalkar, et al.
Molecular Syndromology
|
August 23, 2021
Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society
Mara Dierssen, Yann Herault, Pablo Helguera, et al.
Orthopaedic Journal of Sports Medicine
|
July 11, 2020
Return to Sport After Anterior Cruciate Ligament Injury: Panther Symposium ACL Injury Return to Sport Consensus Group
Sean J Meredith, Thomas Rauer, Terese L Chmielewski, et al.
Orthopaedic Journal of Sports Medicine
|
December 8, 2022
Regulatory and Ethical Aspects of Orthobiologic Therapies
Iain R Murray, Jorge Chahla, Sarah J Wordie, et al.
Orthopaedic Journal of Sports Medicine
|
June 24, 2021
Biologic Association Annual Summit: 2020 Report
Rachel M Frank, Seth L Sherman, Jorge Chahla, et al.
The New England Journal of Medicine
|
March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
M Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Page
of 94
Search research articles
Search
Showing results (921-930 of 935) with videos related to
Sort By:
Page
of 94
Lancet (London, England)
|
June 6, 2024
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Hans Gelderblom, Vivek Bhadri, Silvia Stacchiotti, et al.
Scientific Reports
|
October 23, 2020
Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome
Cristina E Trevino, Aaron M Holleman, Holly Corbitt, et al.
Blood
|
March 31, 2023
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia
Zhenhua Li, Ti-Cheng Chang, Jacob J Junco, et al.
American Journal of Human Genetics
|
June 17, 2026
Complete chromosome 21 centromere sequencing of families with Down syndrome
F Kumara Mastrorosa, Alessia Daponte, Luciana de Gennaro, et al.
The Journal of Molecular Diagnostics : JMD
|
January 1, 2008
Consensus characterization of 16 FMR1 reference materials: a consortium study
Jean Amos Wilson, Victoria M Pratt, Amit Phansalkar, et al.
Molecular Syndromology
|
August 23, 2021
Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society
Mara Dierssen, Yann Herault, Pablo Helguera, et al.
Orthopaedic Journal of Sports Medicine
|
July 11, 2020
Return to Sport After Anterior Cruciate Ligament Injury: Panther Symposium ACL Injury Return to Sport Consensus Group
Sean J Meredith, Thomas Rauer, Terese L Chmielewski, et al.
Orthopaedic Journal of Sports Medicine
|
December 8, 2022
Regulatory and Ethical Aspects of Orthobiologic Therapies
Iain R Murray, Jorge Chahla, Sarah J Wordie, et al.
Orthopaedic Journal of Sports Medicine
|
June 24, 2021
Biologic Association Annual Summit: 2020 Report
Rachel M Frank, Seth L Sherman, Jorge Chahla, et al.
The New England Journal of Medicine
|
March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
M Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Page
of 94